Bavachin
Bavachin has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, May 26, 2026: “Bavachin Mitigates Bone Loss via RANKL Inhibition and Runx2 Activation in a Rat Model of Post-menopausal Osteoporosis”.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Animals1
What did studies of bavachin find?
4Studies of bavachin measured 4 outcomes, among them TNFSF11, bone mechanical strength and inflammation.
TNFSF11
downin rats1
1 study
TNFSF11
downin rats1
Bavachin decreases TNFSF11 in ovariectomized rats.
“A decrease in RANKL expression and an upregulation of OPG, Osx, and Runx2 suggest that bavachin effectively modulates bone remodeling pathways and inhibits osteoclast-mediated bone resorption.”
Animalsin ovariectomized rats
Pharmacognosy Magazine
Bone mechanical strength
upin rats1
1 study
Bone mechanical strength
upin rats1
Bavachin improves bone mechanical strength in ovariectomized rats.
“Bavachin treatment attenuated oxidative stress and inflammation, while improving bone turnover markers and mechanical properties.”
Animalsin ovariectomized rats
Pharmacognosy Magazine
Inflammation
downin rats1
1 study
Inflammation
downin rats1
Bavachin decreases inflammation in ovariectomized rats.
“Bavachin treatment attenuated oxidative stress and inflammation, while improving bone turnover markers and mechanical properties.”
Animalsin ovariectomized rats
Pharmacognosy Magazine
Oxidative stress and ROS signaling
downin rats1
1 study
Oxidative stress and ROS signaling
downin rats1
Bavachin decreases oxidative stress and ROS signaling in ovariectomized rats.
“Bavachin treatment attenuated oxidative stress and inflammation, while improving bone turnover markers and mechanical properties.”
Animalsin ovariectomized rats
Pharmacognosy Magazine